Nascent Biotech Inc (NBIO)
Sector • Healthcare Industry • Major Pharmaceutical Preparations |
Industry • Major Pharmaceutical Preparations |
Sector • Healthcare |
News
Nascent Biotech Inc Struggles in Q2 2024 as Losses Mount and Revenue Stagnates
The company disclosed that revenue has tumbled, during the fourth quarter of 2023
The company published Revenue of $0.000144 millions, in the October to December 31 2022
Very imposing 100%, jump in revenue at Nascent Biotech Inc amid the second quarter of 2023